Kaashika Prajaapat

AI exploiter, 2x founder, dappling in BCIxAI

[Kaashika Prajaapat @thetechbarbiee]

@mehuljindal18 @aurorax_ai @_shyam_king_ This will empower so many retailers

[Kaashika Prajaapat @thetechbarbiee]

If true, hilarious

[TeslaFUDKer 🍁⚡️ 𝕏𝕏𝕏 @technoking_420]

Damn Elon moves quick 👀👀👀👀😂😂

[TeslaFUDKer 🍁⚡️ 𝕏𝕏𝕏 @technoking_420]

Damn Elon moves quick 👀👀👀👀😂😂

[Kaashika Prajaapat @thetechbarbiee]

Crazy!

[Mehul Nath Jindal @mehuljindal18]

Introducing Aurora - the Search Engine for IRL

Have you ever had to go shop-to-shop, or ask your friends and family, or spent hours browsing online for weeks, to find out - which business has what you want?

Could be anything from a renting an Apartment, to a Doctor's appointment? Maybe just your favorite shoe in your size at a store nearby?

Now - you can just Ask @aurorax_ai , and it will tell you who has it!

[Mehul Nath Jindal @mehuljindal18]

Introducing Aurora - the Search Engine for IRL

Have you ever had to go shop-to-shop, or ask your friends and family, or spent hours browsing online for weeks, to find out - which business has what you want?

Could be anything from a renting an Apartment, to a Doctor's appointment? Maybe just your favorite shoe in your size at a store nearby?

Now - you can just Ask @aurorax_ai , and it will tell you who has it!

[Rob Miles @robertskmiles]

Attention all companies: I never want to use your AI assistant on your website. I want to use *my* AI assistant on your website

[Deepinder Goyal @deepigoyal]

Hello everyone. Happy Diwali!

Thank you for your criticism, your support and your time over the last two days. Gives me much needed clarity on what we need to explain better:

1. ⁠Temple is not made for India. It’s made for the world. Please check pricing. We don’t expect any more than 1% of Temples being sold in India.

2.⁠ ⁠If you are upset that the pricing is too high, I am sorry. There’s a lot of work that went into Temple, and we priced it at what we think it’s worth. If you think its overpriced, you can wait for user reviews to decide if its worth your money.

3.⁠ ⁠Please do not support us because we are an Indian startup. We want to compete globally. We don’t need/want nationalist support. Support us if you want to support early innovation, which could help you live a better life, and will continue to add more proof to its science over the years.

4.⁠ ⁠There are different audiences which buy products at various levels of proof. Proof goes from whitepaper -> pre-print -> peer reviewed. You are free to sit on the fence until peer reviewed proof arrives. You are free to not believe it even then. Nobody is forcing you to buy. Making announcements is our right; and if we overclaim anywhere, we will inevitably fall into regulatory trouble everywhere in the world.

5.⁠ ⁠We didn’t make any medical claim. Doctors primarily see things from a medical lens, so they see every claim as a medical claim. I repeat – Temple is strictly a fitness + AI device, and we've made no medical claims. Temple is not proven to diagnose or prevent any disease. It doesn't do anything which replaces the need for you to see a doctor.

6.⁠ ⁠The main point of Temple is NOT Brain Flow. That’s what we just started Temple for, and studies on Brain Flow are the first ones getting out.

7.⁠ ⁠The main point of Temple is Entropy (I shared the HomeScreen of Temple three months ago with Entropy as the main thing). Our emails to our waitlisted users only talk about Entropy. We haven’t published anything on Entropy yet. We will. If you want to buy Temple before that, please do. If you don’t want to, don’t.

8.⁠ ⁠Roomdeaf AI is an expansion of the device’s capabilities, and our vision for Temple. It is not a pivot.

9.⁠ ⁠Social media is not the regulator for Temple. Wherever we need regulatory clearances, we will have them before we make any claim needing them.

10. I will post a detailed note on how we calculate Brain Flow, its uses, and most importantly, its limitations in a bit (tomorrow).

[Leo @4eo]

Also I felt comparing Temple to Theranos and putting Deepinder on that photo was hitting below the belt.

Theranos caused real harm to thousands of patients. They may have caused death of many through false blood reports.

No way comparable.

[Shaan @TechWimps]

He's not forcing anyone to buy it. And it's not like trying it will harm anyone's health if it doesn’t work as expected.

So why all this whining, especially from influential doctors?

People will try it if they find it worth the money. If it doesn't deliver, they'll call it out themselves. Why make such a big deal out of it?

[Deepinder Goyal @deepigoyal]

Pre-order at https://t.co/hi9q1VXygW; first 10,000 orders never pay a subscription to use Temple.

[Kaashika Prajaapat @thetechbarbiee]

@deepigoyal This is just the starting!

[Deepinder Goyal @deepigoyal]

Temple is an ambitious project. The team is delusional enough to think we can build this. And we will.

Here's what we are building. Join the ride.

[Kaashika Prajaapat @thetechbarbiee]

And it is out!

This is truly one of a kind device. Unreal to experience.

Humanity’s LAST personal device.

[Deepinder Goyal @deepigoyal]

Temple is an ambitious project. The team is delusional enough to think we can build this. And we will.

Here's what we are building. Join the ride.

[Deepinder Goyal @deepigoyal]

A lot of you have pinged me to ask - why are you doing Temple? Why did you leave a ~$35b company you founded 18 years ago to chase a niche health wearable? This doesn’t sound rational.

Why did I leave Eternal? What are we building at Temple? What’s our vision statement? What do we have in store for humanity?

I am going to tell you in 4 hours from now (drafting the note as we speak). Stay tuned.

PS – holier-than-thou Indian doctors can skip this lol.

[Varun Mayya @waiting4_asi]

The fitness tracking is the least exciting part of temple for me. It’s the best (and lowest exhaustion) form factor for an always on AI device. The Meta Raybans get tiring after a while. I’m also sure it’s in the right spot for silent speech if that takes off.

[Deepinder Goyal @deepigoyal]

@ChandramDutta don't worry. i will get this going, and the rest will follow.

[Eric Ming Chen @ericmchen1]

NeurIPS 2026 Spotlight! 🌟 Physics simulators like MuJoCo MJX are changing robotics. But for studying the sensorimotor learning of speech, there's no equivalent. We built diffTLM, a differentiable vocal tract simulator, to help close that gap. (1/6)

[will brown @willcb]

people are like “why do LLMs always think they’re in an eval lol” and then have bad dreams about forgetting to turn in a homework assignment 10 years ago

[Kaashika Prajaapat @thetechbarbiee]

Excited for this!

[Gauri Gupta @gauri__gupta]

The intelligence frontier keeps advancing every day. Are your agents delivering better outcomes on what matters?

For enterprises, the promise of agents is more work completed reliably, with less human intervention and a lower cost per successful task.

Today, we’re launching @neosigma_ai and our mission to empower every organization to build their own sovereign intelligence lab.

A place to operationalize their knowledge, replay real work, and optimize agents against the outcomes that matter to their business. Where production experience compounds into intelligence the organization owns.

We’re starting with NeoEval, our automated evaluation engine. It turns your production data into evaluation environments - that dynamically evolves along with your users, workflows, and frontier.

A playground for evaluating and optimizing your agents.

Your data. Your institutional knowledge. Now operationalized into evals and compounding intelligence.

Stay tuned for the next few days of updates from NeoSigma.

[Gauri Gupta @gauri__gupta]

The intelligence frontier keeps advancing every day. Are your agents delivering better outcomes on what matters?

For enterprises, the promise of agents is more work completed reliably, with less human intervention and a lower cost per successful task.

Today, we’re launching @neosigma_ai and our mission to empower every organization to build their own sovereign intelligence lab.

A place to operationalize their knowledge, replay real work, and optimize agents against the outcomes that matter to their business. Where production experience compounds into intelligence the organization owns.

We’re starting with NeoEval, our automated evaluation engine. It turns your production data into evaluation environments - that dynamically evolves along with your users, workflows, and frontier.

A playground for evaluating and optimizing your agents.

Your data. Your institutional knowledge. Now operationalized into evals and compounding intelligence.

Stay tuned for the next few days of updates from NeoSigma.